These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Virtual drug discovery and development for neglected diseases through public-private partnerships. Nwaka S; Ridley RG Nat Rev Drug Discov; 2003 Nov; 2(11):919-28. PubMed ID: 14668812 [No Abstract] [Full Text] [Related]
24. Analysis of pharmaceutical safety-related regulatory actions in Japan: do tradeoffs exist between safer drugs and launch delay? Yamada T; Kusama M; Hirai Y; Arnold F; Sugiyama Y; Ono S Ann Pharmacother; 2010 Dec; 44(12):1976-85. PubMed ID: 21098757 [TBL] [Abstract][Full Text] [Related]
26. Identifying quality leads - an important factor in reducing attrition of clinical candidates. Chackalamannil S; Desai MC Curr Opin Drug Discov Devel; 2007 Jul; 10(4):381-2. PubMed ID: 17659478 [No Abstract] [Full Text] [Related]
27. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
28. How clinical is clinical pharmacology? Special consideration of clinical pharmacokinetics. Ritschel WA Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():9S-16S. PubMed ID: 7321664 [No Abstract] [Full Text] [Related]
31. Chemistry strategies in early drug discovery: an overview of recent trends. Colombo M; Peretto I Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762 [TBL] [Abstract][Full Text] [Related]
32. Experiences with learning and confirming in drug and biological development. Patterson SD Clin Pharmacol Ther; 2010 Aug; 88(2):161-3. PubMed ID: 20648033 [TBL] [Abstract][Full Text] [Related]
33. A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. Falagas ME; Fragoulis KN; Karydis I PLoS One; 2006 Dec; 1(1):e11. PubMed ID: 17183637 [TBL] [Abstract][Full Text] [Related]
34. [Responsibilities of clinical pharmacology in the early phase of drug development]. Kuhlmann J Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846 [TBL] [Abstract][Full Text] [Related]
35. The role of innovation in drug development. Drews J; Ryser S Nat Biotechnol; 1997 Dec; 15(13):1318-9. PubMed ID: 9415870 [No Abstract] [Full Text] [Related]
36. Alternative business models for drug discovery. Bunin BA; Ekins S Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585 [No Abstract] [Full Text] [Related]
37. Improving the efficiency of the development of drugs for stroke. Howells DW; Sena ES; O'Collins V; Macleod MR Int J Stroke; 2012 Jul; 7(5):371-7. PubMed ID: 22712738 [TBL] [Abstract][Full Text] [Related]
38. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France. Napper AD IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316 [No Abstract] [Full Text] [Related]
39. Looking forward in pharmaceutical process chemistry. Davies IW; Welch CJ Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417 [TBL] [Abstract][Full Text] [Related]
40. Two decades of new drug development for central nervous system disorders. Kesselheim AS; Hwang TJ; Franklin JM Nat Rev Drug Discov; 2015 Dec; 14(12):815-6. PubMed ID: 26585536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]